Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Primary: To determine the relative bioavailability of MOA-728, an investigational drug,
administered orally in both the capsule and tablet formulations to methadone maintenance
subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally
and subcutaneously to methadone maintenance subjects using the oral-cecal transit time.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.